Literature DB >> 18216015

GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes.

David P Sparling1, Beth A Griesel, Juston Weems, Ann Louise Olson.   

Abstract

The insulin-responsive glucose transporter, GLUT4, is regulated in various physiologic states at the transcriptional level. When expressed in transgenic mice, the human GLUT4 promoter is governed by two cis-acting sequences: an MEF2 binding domain and Domain I, that function both as positive and negative regulators depending on the physiologic state. MEF2 proteins and GLUT4 enhancer factor (GEF) are known ligands for these cis-acting elements, but their mechanism of action is unclear. To begin to understand this important process, we have characterized GEF structural domains and its interactions with the MEF2A isoform. We find that the C terminus of GEF comprises its DNA-binding domain, but does not contribute to GEF homo-oligomerization. We also have found that GEF dimerizes with increased affinity to a hypophosphorylated form of MEF2A. Furthermore, we demonstrated that MEF2A binding to its cognate binding site can increase the DNA binding activity of GEF to Domain I, suggesting a novel mechanism for MEF2A transcriptional activation. Finally, we have demonstrated that the transcriptional co-repressor HDAC5 can interact with GEF in the absence of MEF2 proteins and specifically inhibit GLUT4 promoter activity. These findings lead to the hypothesis that GEF and the MEF2 proteins form a complex on the GLUT4 promoter that allows for recruitment of transcriptional co-regulators (repressors and/or activators) to control GLUT4 promoter activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216015      PMCID: PMC2276327          DOI: 10.1074/jbc.M800481200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.

Authors:  J Lu; T A McKinsey; C L Zhang; E N Olson
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

2.  Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.

Authors:  Christine Y Christ-Roberts; Thongchai Pratipanawatr; Wilailak Pratipanawatr; Rachele Berria; Renata Belfort; Sangeeta Kashyap; Lawrence J Mandarino
Journal:  Metabolism       Date:  2004-09       Impact factor: 8.694

3.  Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene.

Authors:  Paul S MacLean; Donghai Zheng; Jared P Jones; Ann Louise Olson; G Lynis Dohm
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

4.  GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure.

Authors:  J T Brozinick; S C McCoid; T H Reynolds; N A Nardone; D M Hargrove; R W Stevenson; S W Cushman; E M Gibbs
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

5.  The MEF2A and MEF2D isoforms are differentially regulated in muscle and adipose tissue during states of insulin deficiency.

Authors:  S Mora; C Yang; J W Ryder; D Boeglin; J E Pessin
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

6.  Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5.

Authors:  Michael P Czubryt; John McAnally; Glenn I Fishman; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

7.  Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle.

Authors:  Sean L McGee; Mark Hargreaves
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

8.  Regulation of the human GLUT4 gene promoter: interaction between a transcriptional activator and myocyte enhancer factor 2A.

Authors:  John B Knight; Craig A Eyster; Beth A Griesel; Ann Louise Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

9.  Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats.

Authors:  F H Ziel; N Venkatesan; M B Davidson
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

10.  AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.

Authors:  Burton F Holmes; David B Lang; Morris J Birnbaum; James Mu; G Lynis Dohm
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-27       Impact factor: 4.310

View more
  20 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

Review 2.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

3.  Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation.

Authors:  Juston Weems; Ann Louise Olson
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 4.  Selective class IIa HDAC inhibitors: myth or reality.

Authors:  Eros Di Giorgio; Enrico Gagliostro; Claudio Brancolini
Journal:  Cell Mol Life Sci       Date:  2014-09-05       Impact factor: 9.261

5.  TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle.

Authors:  Jin-Ho Koh; Matthew L Johnson; Surendra Dasari; Nathan K LeBrasseur; Ivan Vuckovic; Gregory C Henderson; Shawna A Cooper; Shankarappa Manjunatha; Gregory N Ruegsegger; Gerald I Shulman; Ian R Lanza; K Sreekumaran Nair
Journal:  Diabetes       Date:  2019-05-14       Impact factor: 9.461

6.  Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle.

Authors:  Marta Murgia; Thomas E Jensen; Marzia Cusinato; Marta Garcia; Erik A Richter; Stefano Schiaffino
Journal:  J Physiol       Date:  2009-07-13       Impact factor: 5.182

7.  Rab5 activity regulates GLUT4 sorting into insulin-responsive and non-insulin-responsive endosomal compartments: a potential mechanism for development of insulin resistance.

Authors:  Kandice L Tessneer; Robert M Jackson; Beth A Griesel; Ann Louise Olson
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

8.  Insulin regulates fusion of GLUT4 vesicles independent of Exo70-mediated tethering.

Authors:  Vladimir A Lizunov; Ivonne Lisinski; Karin Stenkula; Joshua Zimmerberg; Samuel W Cushman
Journal:  J Biol Chem       Date:  2009-01-19       Impact factor: 5.157

9.  Acute inhibition of fatty acid import inhibits GLUT4 transcription in adipose tissue, but not skeletal or cardiac muscle tissue, partly through liver X receptor (LXR) signaling.

Authors:  Beth A Griesel; Juston Weems; Robert A Russell; E Dale Abel; Kenneth Humphries; Ann Louise Olson
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

10.  The beneficial effects of exercise in rodents are preserved after detraining: a phenomenon unrelated to GLUT4 expression.

Authors:  Alexandre M Lehnen; Natalia M Leguisamo; Graziela H Pinto; Melissa M Markoski; Kátia De Angelis; Ubiratan F Machado; Beatriz Schaan
Journal:  Cardiovasc Diabetol       Date:  2010-10-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.